Steve Jensen Joins The Weinberg Group (now ProPharma Group)

February 3, 2015

The Weinberg Group (now ProPharma Group), the leading FDA consulting firm, is pleased to announce that Steve Jensen has joined us as Senior Vice President, Head of Regulatory Consulting. Steve has over 20 years of industry experience including executive roles at Iroko, Verus and SkyePharma. He has had responsibility for products under development and launch, including managing multiple FDA submissions and meetings.
"Steve is a welcome addition to our team," said Matthew Weinberg, CEO. "His ability to synthesize a deep regulatory background in tandem with scientific expertise is the essence of what we do. His addition will strengthen the best team in the industry. We look forward to the leadership and guidance Steve will provide."
Steve Jensen

Senior Vice President, Head of Regulatory Consulting

+1 706.286.8841 direct

+1 706.371.8206 mobile

TAGS:

October 3, 2018

The Weinberg Group (now ProPharma Group) Adds Experts to Team

WASHINGTON, DC – OCTOBER 3, 2018 – The Weinberg Group (now ProPharma Group), is growing. In addition to people, the company has also expanded its capabilities. Building upon its role as the most...

January 28, 2019

ProPharma Group Announces the Acquisition of The Weinberg Group

Overland Park, KS — ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading...

January 28, 2019

ProPharma Group Acquires The Weinberg Group

ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Washington D.C.-based The Weinberg Group Inc. The Weinberg Group is a leading provider of regulatory and...